Evaluating the Stasis Supplement to Reduce Side Effects of ADHD Stimulant Medications in Adults Aged 18 to 55

What this Trial Is About

Researchers are evaluating the effects of the Stasis dietary supplement on reducing oxidative stress, cortisol levels, and side effects related to stimulant medications used for ADHD in adults aged 18 to 55. This randomized, triple-blind, placebo-controlled clinical trial aims to understand how the supplement may help with symptoms like sleep difficulties, irritability, anxiety, and brain fog over a three-month period. The study is sponsored by Outliers, Inc. and includes participants who are stable on stimulant medication and supplements. Participants are randomly assigned to either the Stasis supplement group or a placebo group. The Stasis supplement is taken twice daily the daytime dose with stimulant medication and food, and the nighttime dose 30 minutes before bedtime on an empty stomach. The placebo is designed to match the supplement in taste and appearance. The trial lasts three months, during which both groups follow their usual stimulant medication and habits. During the study, researchers will measure changes in oxidative stress and cortisol levels at the beginning and end of the trial. They will also assess sleep quality, irritability, focus, sociability, mood, stress, appetite, and blood levels of Vitamin C and CoQ10 monthly. Safety and adherence will be monitored throughout. Participants are expected to maintain stable medication and supplement use and will be followed for the full three-month duration.

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications